Education
About Us
Working with TipRanks
Follow Us
RedHill Biopharma Ltd (RDHL)
:RDHL
RDHL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.30 - $19.14
Previous CloseN/A
Volume5.64K
Average Volume (3M)943.85K
Market Cap
$3.00M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Aug 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,295,345
10 Day Avg. Volume2,757,296
30 Day Avg. Volume943,846
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2.00Price Target Upside52.67% Upside
Rating ConsensusHold
Number of Analyst Covering0
RedHill Biopharma News
RDHL FAQ
What was RedHill Biopharma Ltd’s price range in the past 12 months?
RedHill Biopharma Ltd lowest stock price was $1.30 and its highest was $19.14 in the past 12 months.
What is RedHill Biopharma Ltd’s market cap?
RedHill Biopharma Ltd’s market cap is $3.00M.
When is RedHill Biopharma Ltd’s upcoming earnings report date?
RedHill Biopharma Ltd’s upcoming earnings report date is Aug 14, 2025 which is in 12 days.
How were RedHill Biopharma Ltd’s earnings last quarter?
Currently, no data Available
Is RedHill Biopharma Ltd overvalued?
According to Wall Street analysts RedHill Biopharma Ltd’s price is currently Undervalued.
Does RedHill Biopharma Ltd pay dividends?
RedHill Biopharma Ltd does not currently pay dividends.
What is RedHill Biopharma Ltd’s EPS estimate?
RedHill Biopharma Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RedHill Biopharma Ltd have?
RedHill Biopharma Ltd has 2,295,345 shares outstanding.
What happened to RedHill Biopharma Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of RedHill Biopharma Ltd?
Currently, no hedge funds are holding shares in RDHL
Company Description
RedHill Biopharma Ltd
RedHill Biopharma (RDHL) is a specialty biopharmaceutical company focused on the development and commercialization of innovative therapies for gastrointestinal and infectious diseases. The company is headquartered in Israel and operates primarily in the pharmaceutical sector, offering a range of products aimed at addressing significant medical needs in these areas.
Technical Analysis
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---